Skip to content

Serotonin: all studies

Page 270 of 401: studies 2,691 to 2,700 of 4,004, newest first. Back to the serotonin overview

Research

Microbiome–Gut–Brain Axis Modulation: New Approaches in Treatment of Neuropsychological and Gastrointestinal Functional Disorders

ACS Medicinal Chemistry Letters May 11, 2023 Robert B. Kargbo 15 citations

The gut-brain axis (GBA) refers to the sophisticated bidirectional communication system connecting the digestive system with the central nervous system. This interaction is enabled by a series of intricate signaling processes, encompassing various neuro-immune and hormonal pathways. The association between the gut microbiome and mental health has garnered immense scientific and public interest,...

DOI: 10.1021/acsmedchemlett.3c00168 (opens in new tab) Full text (opens in new tab) Gut–brain axis Gut microbiome Lysergic acid Enteric nervous system +1

Editorial: Pharmacology of new psychoactive substances

Frontiers in Pharmacology May 9, 2023 Kabirullah Lutfy, Robert N. Pechnick, Nissar A. Darmani 1 citation

Pharmacology of new psychoactive substancesSeveral classes of novel psychoactive substances have been introduced in illicit markets throughout the world and more are being developed.They present major law enforcement challenges and global public health threats.However, there is limited information on their harmful effects on the central nervous, cardiovascular, respiratory, and gastrointestinal...

NMA/AGSM/2022/BCS/009 - Reversal and Preventive Pleiotropic Mechanisms Involved in the Antipsychotic-Like Effect of Geraniol, Acyclic Isoprenoid Monoterpene in Ketamine-Induced Psychosis in Mice

Nigerian Medical Journal May 5, 2023 C. Uruaka, O. Georgewill, OU Georgewill

Background Schizophrenia is a chronic neuropsychiatric disease characterized by neurochemical, neurotrophic, and oxido-inflammatory derangements. Geraniol is a neuroactive acyclic isoprenoid monoterpene, which has been reported to demonstrate depressant and antioxidant/anti-inflammatory activities. Herein, we investigated whether geraniol could prevent or reverse ketamine-induced...

Dosing and Therapeutic Conduct in Administration Sessions in Substance-Assisted Psychotherapy: A Systematized Review

Journal of Humanistic Psychology May 3, 2023 Sascha Thal, Michelle Wieberneit, Jason M. Sharbanee et al. 6 citations

While the potential of serotonergic psychedelics and related substances as adjuncts in substance-assisted psychotherapy (SAPT) has been investigated for the treatment of several disorders, evidence for the appropriate therapeutic conduct in administration sessions is sparse. In this article, we discuss the current evidence for best therapeutic practice during administration sessions with...

DOI: 10.1177/00221678231168516 (opens in new tab) Psycinfo Psychotherapist Medline Psychological intervention +3

The Future for Psychedelic Agents in the Treatment of Posttraumatic Stress Disorder

The Journal for Nurse Practitioners May 1, 2023 Amy L Haycraft

Posttraumatic stress disorder (PTSD) treatment options, including the potential use of psychedelic-assisted therapy, are reviewed. Traditional PTSD treatment remains ineffective for many, and includes, trauma focused cognitive behavioral therapy, eye movement desensitization and remodeling, and selective serotonin reuptake inhibitors. Evidence has shown that with further supportive research,...

(267) Ecstasy' - Accurate or Deceptive Name? A Systematic Review of MDMA Effects on the Male Sexual Response Cycle

The Journal of Sexual Medicine May 1, 2023 Julie Suyama, Alexandra Dubinskaya, Karyn Eilber et al.

3,4-Methylenedioxymethamphetamine (MDMA, ‘Ecstasy’ or ‘Molly’) is a synthetic psychostimulant and entactogenic drug of abuse that augments feelings of pleasure, increases energy, and distorts sensory perception. MDMA increases serotonin, dopamine, and norepinephrine neurotransmission within the mesolimbic reward pathway, which impacts human sexual function. While dopamine is implicated as a...

Central Basis For MDMA (ecstasy) Induced Hyponatremia

Physiology May 1, 2023 Joshua Wyrosdic, Zahra Thirouin, Charles Bourque

Clinical studies have shown that hyponatremia can be induced by the ingestion of the recreational drug MDMA (3,4-Methyl​enedioxy​methamphetamine, ecstasy) when combined with a water intake (Baggot et al., 2016). However, the mechanisms by which MDMA induces hyponatremia is unknown. Hyponatremia is a life-threatening condition that causes rapid swelling of the brain and is commonly encountered...

Off-target activity of NBOMes and NBOMe analogs at the µ opioid receptor.

Archives of Toxicology May 1, 2023 Marie H Deventer, Mattias Persson, Antonio Laus et al. 7 citations

New psychoactive substances (NPS) are introduced on the illicit drug market at a rapid pace. Their molecular targets are often inadequately elucidated, which contributes to the delayed characterization of their pharmacological effects. Inspired by earlier findings, this study set out to investigate the µ opioid receptor (MOR) activation potential of a large set of psychedelics, substances which...

Psychedelics as Transformative Therapeutics.

American Journal of Psychiatry May 1, 2023 Bryan L. Roth, Ryan H. Gumpper 55 citations

Over the past decade, psychedelic compounds have emerged as potentially transformative therapeutics for a variety of intractable neuropsychiatric conditions. However, historically most of the basic science has utilized these compounds as probes to interrogate various endogenous neurotransmitter systems-mainly the serotonin 5-HT2A receptor. With the renewed interest in utilizing these compounds...

DOI: 10.1176/appi.ajp.20230172 (opens in new tab) Full text (opens in new tab) Hallucinogenic drugs Pharmacokinetics Psychedelics Psychopharmacology

Unblinding and demand characteristics in the treatment of depression.

Journal of Affective Disorders May 1, 2023 Guy M. Goodwin, Megan Croal, Lindsey Marwood et al. 13 citations

Blinding of treatment allocation in clinical trials in psychiatry is regarded as an ideal. The potential impact of unblinding chimes with a general concern for psychological research: so-called demand characteristics can undermine confidence in findings from experimental and clinical studies. Scepticism can result in nihilism. The reliance on subjective report of symptoms in clinical trials of...

DOI: 10.1016/j.jad.2023.02.030 (opens in new tab) Full text (opens in new tab) Demand characteristics Unblinding Clinical-trials blinding Masking +7